NDLI: Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study

Content Provider	Springer Nature : BioMed Central
Author	Mc Namara, Kevin P George, Johnson O'Reilly, Sharleen L Jackson, Shane L Peterson, Gregory M Howarth, Helen Bailey, Michael J Duncan, Gregory Trinder, Peta Morabito, Elizabeth Finch, Jill Bunker, Stephen Janus, Edward Emery, Jon Dunbar, James A
Abstract	Background Cardiovascular disease (CVD) is the leading cause of death globally. Community pharmacist intervention studies have demonstrated clinical effectiveness for improving several leading individual CVD risk factors. Primary prevention strategies increasingly emphasise the need for consideration of overall cardiovascular risk and concurrent management of multiple risk factors. It is therefore important to demonstrate the feasibility of multiple risk factor management by community pharmacists to ensure continued currency of their role. Methods/Design This study will be a longitudinal pre- and post-test pilot study with a single cohort of up to 100 patients in ten pharmacies. Patients aged 50-74 years with no history of heart disease or diabetes, and taking antihypertensive or lipid-lowering medicines, will be approached for participation. Assessment of cardiovascular risk, medicines use and health behaviours will be undertaken by a research assistant at baseline and following the intervention (6 months). Validated interview scales will be used where available. Baseline data will be used by accredited medicines management pharmacists to generate a report for the treating community pharmacist. This report will highlight individual patients' overall CVD risk and individual risk factors, as well as identifying modifiable health behaviours for risk improvement and suggesting treatment and behavioural goals. The treating community pharmacist will use this information to finalise and implement a treatment plan in conjunction with the patient and their doctor. Community pharmacists will facilitate patient improvements in lifestyle, medicines adherence, and medicines management over the course of five counselling sessions with monthly intervals. The primary outcome will be the change to average overall cardiovascular risk, assessed using the Framingham risk equation. Discussion This study will assess the feasibility of implementing holistic primary CVD prevention programs into community pharmacy, one of the most accessible health services in most developed countries. Trial registration Australia and New Zealand Clinical Trial Registry Number: ACTRN12609000677202
Related Links	https://bmchealthservres.biomedcentral.com/counter/pdf/10.1186/1472-6963-10-264.pdf
Ending Page	8
Page Count	8
Starting Page	1
File Format	HTM / HTML
ISSN	14726963
DOI	10.1186/1472-6963-10-264
Journal	BMC Health Services Research
Issue Number	1
Volume Number	10
Language	English
Publisher	BioMed Central
Publisher Date	2010-09-07
Access Restriction	Open
Subject Keyword	Public Health Health Administration Health Informatics Nursing Research Community Pharmacy Community Pharmacist Medicine Management Human Research Ethic Committee Home Medicine Review
Content Type	Text
Resource Type	Article
Subject	Health Policy

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study

The pharmacist assessment of adherence, risk and treatment in cardiovascular disease (paart cvd) pilot study.

Pharmacist assessment of adherence, risk and treatment in cardiovascular disease (PAART CVD)

A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project.

Positioning pharmacists’ roles in primary health care: a discourse analysis of the compensation plan in Alberta, Canada

Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence?

Factors influencing pharmacists’ adoption of prescribing: qualitative application of the diffusion of innovations theory

English community pharmacists’ experiences of using electronic transmission of prescriptions: a qualitative study

Awareness of Cardiovascular Disease Risk Factors by Community Pharmacists in Saudi Arabia.

Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study

Similar Documents

Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study

The pharmacist assessment of adherence, risk and treatment in cardiovascular disease (paart cvd) pilot study.

Pharmacist assessment of adherence, risk and treatment in cardiovascular disease (PAART CVD)

A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project.

Positioning pharmacists’ roles in primary health care: a discourse analysis of the compensation plan in Alberta, Canada

Does the presence of a pharmacist in primary care clinics improve diabetes medication adherence?

Factors influencing pharmacists’ adoption of prescribing: qualitative application of the diffusion of innovations theory

English community pharmacists’ experiences of using electronic transmission of prescriptions: a qualitative study

Awareness of Cardiovascular Disease Risk Factors by Community Pharmacists in Saudi Arabia.

Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study